Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects

Eugene R. Viscusi(Thomas Jefferson University), Sue Hobson, Neil Singla(Huntington Hospital), Stewart W. McCallum(Harvard University), Tong J. Gan(The University of Texas MD Anderson Cancer Center), Randall J. Mack, Wei Du(Cubist Pharmaceuticals (United States)), Sergio D. Bergese(Stony Brook University Hospital)
Regional Anesthesia & Pain Medicine
February 7, 2019
Cited by 7


Related Papers